venBio Partners LLC
- SEC CIK
- 0001776382
- Latest filing
- Aug 14, 2026
Holdings in Q2 2024
Holdings as of Jun 30, 2024, filed Aug 14, 2024. Long positions only; changes compare share counts with Q1 2024.
- Positions
- 6
- +1 vs. Q1 2024
- Portfolio value
- $231.5M
- −$50.4M (−17.9%) vs. Q1 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PHVSPharvaris N.V. | COM | 4,289,304 | $80.6M | 34.8% | 00.0% | Unchanged | History |
| ALXOAlx Oncology Holdings Inc | COM | 9,699,925 | $58.5M | 25.3% | 00.0% | Unchanged | History |
| ALMSAlumis Inc. | COM | 2,826,048 | $37.6M | 16.2% | +2,826,048 | New | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 1,035,396 | $31.2M | 13.5% | 00.0% | Unchanged | History |
| SLRNACELYRIN, Inc. | COM | 3,852,470 | $17.0M | 7.3% | 00.0% | Unchanged | History |
| ELEVElevation Acquisition Group Inc. | COM | 2,434,255 | $6.57M | 2.8% | −261,878−9.7% | Reduced | History |